Skip to main content
Clinical Trials/CTRI/2020/07/026914
CTRI/2020/07/026914CompletedPhase 4

Comparative effects of intravenous Diclofenac and Buprenorphine for pain relief in patients with Acute Pancreatitis : A Randomized Controlled Study

Mayank Saini0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Acute pancreatitis as defined by the clinical symptoms, elevation in serum amylase level(more than three times the upper limit of normal range) or imaging finding
  • Abdominal pain at the time of enrolment
  • Patients who have presented to the hospital within the first 5 days after onset of pain.

Exclusion Criteria

  • Patients of acute pancreatitis who have renal failure (Serum Creatinine > 1.5 mg/dl) at presentation
  • Patients who were contraindicated to Opioids and NSAIDS
  • Who already take Opioids and NSAIDS for other reasons
  • Patients with history of coronary artery disease
  • Patients with altered mental status
  • Patients with imaging evidence of chronic pancreatitis
  • Patients requiring ventilatory support

Investigators

Sponsor
Mayank Saini

Similar Trials

A study to find the effectiveness of two... | Clinical Trial